Skip to content
10-Q

Quarterly Report

Regenerative Medical Technology Group Inc. RMTG

0001213900-25-112710

← back to feed
Filed
Nov 19, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 13.14M sh
Shares Diluted Q3 2025 · Sep 30, 2025 12.54M sh
Shares Diluted Q3 2025 · Sep 30, 2025 12.54M sh
Shares Diluted Q3 2025 · Sep 30, 2024 12.54M sh
Shares Diluted Q3 2025 · Sep 30, 2024 12.53M sh
Capex Q3 2025 · Sep 30, 2025 $335.41K
Capex Q3 2025 · Sep 30, 2024 $165.42K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$744.72K
Operating Cash Flow Q3 2025 · Sep 30, 2024 $471.31K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.19M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.17M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$30.05M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$29.02M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$27.36M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$26.72M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$25.83M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$21.8M
Current Liabilities Q3 2025 · Sep 30, 2025 $17.27M
Current Liabilities Q3 2025 · Dec 31, 2024 $28.97M
Total Liabilities Q3 2025 · Sep 30, 2025 $34.57M
Total Liabilities Q3 2025 · Dec 31, 2024 $31.18M
Current Assets Q3 2025 · Sep 30, 2025 $1.51M
Current Assets Q3 2025 · Dec 31, 2024 $1.25M
Total Assets Q3 2025 · Sep 30, 2025 $4.52M
Total Assets Q3 2025 · Dec 31, 2024 $3.82M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.35
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.51
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.39
Eps Basic Q3 2025 · Sep 30, 2025 −$0.35
Eps Basic Q3 2025 · Sep 30, 2025 −$0.51
Eps Basic Q3 2025 · Sep 30, 2024 −$0.07
Eps Basic Q3 2025 · Sep 30, 2024 −$0.39
Net Income Q3 2025 · Sep 30, 2025 −$4.35M
Net Income Q3 2025 · Sep 30, 2025 −$6.42M
Net Income Q3 2025 · Sep 30, 2024 −$887.15K
Net Income Q3 2025 · Sep 30, 2024 −$4.92M
Operating Income Q3 2025 · Sep 30, 2025 −$445.76K
Operating Income Q3 2025 · Sep 30, 2025 −$560.89K
Operating Income Q3 2025 · Sep 30, 2024 $19.65K
Operating Income Q3 2025 · Sep 30, 2024 −$299.44K
Gross Profit Q3 2025 · Sep 30, 2025 $501.56K
Gross Profit Q3 2025 · Sep 30, 2025 $2.03M
Gross Profit Q3 2025 · Sep 30, 2024 $747.06K
Gross Profit Q3 2025 · Sep 30, 2024 $1.84M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $678.98K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.5M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $239.25K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $753.74K
Revenue Q3 2025 · Sep 30, 2025 $1.18M
Revenue Q3 2025 · Sep 30, 2025 $3.53M
Revenue Q3 2025 · Sep 30, 2024 $986.31K
Revenue Q3 2025 · Sep 30, 2024 $2.6M